The Latest Cardiac and Vascular News
TOKYO, July 7, 2025 /PRNewswire/ — Simplex Quantum, an AI-driven healthcare technology company, is proud to announce that Dr. Marco Perez, Associate Professor of Medicine at Stanford University and a renowned expert in cardiac electrophysiology, has agreed to act as an advisor to Simplex…
AI-Powered Heart Failure Detection Technology Recognized Among Asia-Pacific’s Top 20 MedTech Startups TOKYO, May 29, 2025 /PRNewswire/ — Simplex Quantum, a Tokyo-based medical technology startup specializing in AI-driven heart health solutions, has been selected as one of 20…
Published in the International Journal of Cardiology, new study demonstrates 91.6% accuracy and introduces the HF-index for on-demand severity tracking TOKYO, April 24, 2025 /PRNewswire/ — Simplex Quantum, in collaboration with the University of Tokyo Hospital, today announced the…
Medical information technology company receives investment of JPY550 million TOKYO–(BUSINESS WIRE)–SIMPLEX QUANTUM, Inc. has raised JPY550 million in a round of Series A funding. Simplex Holdings, Inc., along with the Technology Ventures No. 5 Investment Limited Partnership managed by ITOCHU Technology Ventures (ITV), and ITOCHU Corporation, invested the funds. This investment […]
The University of Aizu collaborated on development of the technology designed to help verify individuals’ identity and protect data integrity TOKYO–(BUSINESS WIRE)–SIMPLEX QUANTUM, Inc. has completed registration in the United States of a patent for a system designed to accurately authenticate an individual’s electrocardiogram (ECG) waveform data. Patent US 11,500,975 B2 […]
University of Tokyo Hospital collaborated on development of the technology designed to reduce the burden on medical staff performing heart failure staging TOKYO–(BUSINESS WIRE)–SIMPLEX QUANTUM, Inc. has completed registration in the United States of a patent for technology designed to use artificial intelligence (AI) to stage heart failure. Patent US […]
